scispace - formally typeset
V

Vic Hasselblad

Researcher at Duke University

Publications -  215
Citations -  25675

Vic Hasselblad is an academic researcher from Duke University. The author has contributed to research in topics: Randomized controlled trial & Heart failure. The author has an hindex of 80, co-authored 215 publications receiving 24087 citations. Previous affiliations of Vic Hasselblad include RTI International & University of California, Irvine.

Papers
More filters
Journal ArticleDOI

Effect of nesiritide in patients with acute decompensated heart failure.

Christopher M. O'Connor, +58 more
TL;DR: In this article, Nesiritide was not associated with an increase or a decrease in the rate of death and rehospitalization and had a small, nonsignificant effect on dyspnea when used in combination with other therapies.
Journal ArticleDOI

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

TL;DR: A primary objective was to systematically review the characteristics of conventional and new methods of Pap testing, including neural network computerized imaging of Papanicolaou smear slides, and one that uses neural networks.
Journal ArticleDOI

Effect of Clinical Decision-Support Systems: A Systematic Review

TL;DR: Both commercially and locally developed CDSSs are effective at improving health care process measures across diverse settings, but evidence for clinical, economic, workload, and efficiency outcomes remains sparse.
Journal ArticleDOI

Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports.

TL;DR: The type and number of interventions varied greatly, and future studies should directly compare different types of intervention to find the most effective.
Journal Article

Effect of Clinical Decision-Support Systems

TL;DR: In this paper, a review summarizes trials of clinical decision support systems implemented in clinical settings to aid decision-making at the point-of-care (POC) level, and concludes that the evidence to support widespread use of CDSSs is lacking.